Biotech – the red-hot, high risk investment story

MoneyWeek magazine

Latest issue:

Magazine cover
Hard landing?

Don't get crushed by China

The UK's best-selling financial magazine. Take a FREE trial today.
Claim 4 FREE Issues

Biotech - the red-hot, high risk investment story

Biotech stocks have been booming over the last few years. Anyone who has invested will have made some very respectable profits. And it's a bull market that's set to continue for some time yet.

The biggest threat to modern medicine could be a big opportunity too

A crisis is looming which threatens to undermine the basis of modern medicine. As Matthew Partridge explains, that creates opportunities for drugs companies and investors.

A bubble in the biotech sector?

Growth-starved investors have piled into the Nasdaq in recent years, swelling the exchange’s biotech index.

Shire’s $30bn move on Baxalta

Pharma giant Shire has made an unsolicited $30bn all-share offer for America’s Baxalta.

Three biotech merger targets to buy now

Professional investor Ailsa Craig picks three biotech stocks that are ripe for takeover.

Three bubbles that are ready to pop

Cheap money, artificial credit, and zero interest policies have created all sorts of bubbles since the financial crisis of 2008. Dominic Frisby looks at three that are ready to pop.

Chart of the week: The biotech bubble

The Nasdaq Biotechnology index has risen almost sixfold in the past ten year. In the past five, it has quadrupled.

Three of the best biotech stocks to buy now

Biotechnology firms are benefiting from demand from ageing populations. But as Dr Daniel Koller explains, there’s more to the biotech boom than that.

Three biotech stocks to buy as the sector comes of age

Investment manager Carl Harald Janson tips three biotech stocks to profit from the full range of opportunities this exciting sector has to offer.

An exciting future for tech stocks

We live in a golden age of unprecedented technological change. Smart investors should get in early, says Jim Mellon.

Invest for a high-tech future

Technological change is everywhere, says Merryn Somerset Webb. Investors who don’t want to be left behind should read Jim Mellon’s new book.

Showing page 1 of 7